Ira Braunschweig
Hematology & Oncology · Bronx, NYNPI 1013097500
Payments from drug & device makers
Across 161 payments — averaging $2578.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Janssen Research & Development, LLC$293K
- Gilead$61K
- Takeda Pharmaceuticals U.S.A., Inc.$37K
- Bristol Myers Squibb$14K
- Jazz Pharmaceuticals Inc.$6K
- E.r. Squibb & Sons, L.L.C.$3K
- plus $845 from 1 others
What the payments were for
- Consulting fees$5,100100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Janssen Research & Development, LLC | 91 | $293,315 |
| Gilead | 49 | $60,963 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $37,038 |
| Bristol Myers Squibb | 3 | $14,243 |
| Jazz Pharmaceuticals Inc. | 4 | $6,017 |
| E.r. Squibb & Sons, L.L.C. | 1 | $2,700 |
| Amgen | 1 | $845 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecartus$2,400
How this compares
$415,120 in reported general payments places this provider in the 80th percentile of 967 hematology & oncology providers in New York.
Other hematology & oncology in Bronx
- Vicky MakkerNew York$27.1M
- Alison MoskowitzNew York$22.7M
- Ajai ChariNew York$22.4M
- Yelena JanjigianNew York$16.9M
- Alexander LesokhinNew York$11.9M
- John MascarenhasNew York$11.8M
- Maria PalombaNew York$11.6M
- Richard ZunigaBabylon$10.9M
- Scott TagawaNew York$10.3M
- Mohammad Abdul HayNew York$9.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.